Lymphoma, diffuse large B-cell
Clinical trials for Lymphoma, diffuse large B-cell explained in plain language.
Never miss a new study
Get alerted when new Lymphoma, diffuse large B-cell trials appear
Sign up with your email to follow new studies for Lymphoma, diffuse large B-cell, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: early trial of LY4584180 begins
Disease control Recruiting nowThis study is testing a new experimental drug called LY4584180 in adults with certain types of blood cancer (like lymphoma) that have not improved after at least two prior treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shr…
Matched conditions: LYMPHOMA, DIFFUSE LARGE B-CELL
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Off-the-Shelf CAR-T cells take on tough blood cancers
Disease control Recruiting nowThis study tests a new CAR-T therapy made from donor cells, so it's ready to use without waiting for a patient's own cells to be modified. It targets two proteins on cancer cells to lower the chance of the cancer coming back. About 178 adults with relapsed or refractory B-cell ly…
Matched conditions: LYMPHOMA, DIFFUSE LARGE B-CELL
Phase 1/2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC